Long-Term Outcome of High Dose Intensity Modulated Radiation Therapy for Patients With Clinically Localized Prostate Cancer

Journal of Urology

Volumn 176, Issue 4, 2006, Pages 1415-1419

  Zelefsky, Michael J ^a   Chan, Heather ^a   Hunt, Margie ^a   Yamada, Yoshiya ^a   Shippy, Alison M ^a   Amols, Howard ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

intensity modulated; prostatic neoplasms; radiotherapy; toxicity

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER RELAPSE; CANCER RISK; CATHETERIZATION; FOLLOW UP; HUMAN; INTENSITY MODULATED RADIATION THERAPY; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; PRIORITY JOURNAL; PROSTATE CANCER; RADIATION DOSE; RADIATION INJURY; RECTUM HEMORRHAGE; TIME SERIES ANALYSIS; TREATMENT OUTCOME; URETHRA STRICTURE;

AGED; AGED, 80 AND OVER; DISEASE-FREE SURVIVAL; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RADIATION TOLERANCE; RADIOTHERAPY, INTENSITY-MODULATED; RECTUM; TREATMENT OUTCOME; URINARY TRACT;

EID: 33748096108     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2006.06.002     Document Type: Article

References (18)

1. Pollack A., Zagars G.K., Starkschall G., Antolak J.A., Lee J.J., Huang E., et al. Prostate cancer radiation dose response. results of the M. D. Anderson phase III randomized trial. Int J Radiat Oncol Biol Phys 53 (2002) 1097
2. Zietman A.L., DeSilvio M.L., Slater J.D., Rossi C.J., Miller D.W., Adams J.A., et al. Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate. JAMA 294 (2005) 1233
3. Zelefsky M.J., Fuks Z., Hunt M., Lee H.J., Lombardi D., Ling C.C., et al. High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer. J Urol 166 (2001) 876
4. Meerleer G., Vakaet L., Meersschout S., Villeirs G., Verbaeys A., Oosterlinck W., et al. Intensity modulated radiotherapy as primary treatment for prostate cancer. acute toxicity in 114 patients. Int J Radiat Oncol Biol Phys 60 (2004) 777
5. Symon Z., Griffith K.A., McLaughlin W., Sullivan M., and Sandler H.M. Dose escalation for localized prostate cancer. substantial benefit observed with 3D conformal therapy. Int J Radiat Oncol Biol Phys 57 (2003) 384
6. Bey P., Carrie C., Beckendorf V., Ginestet C., Aletti P., Madelis G., et al. Dose escalation with 3D-CRT in prostate cancer. French study of dose escalation with conformal radiotherapy in prostate cancer-preliminary results. Int J Radiat Oncol Biol Phys 48 (2000) 513
7. Pollack A., Hanlon A.L., Horwitz E.M., Feigenberg S.J., Uzzo R.G., and Hanks G.E. Prostate cancer radiotherapy dose response. an update of the Fox Chase experience. J Urol 171 (2004) 1132
8. Cheung R., Tucker S.L., Dong L., and Kuban D. Dose-response for biochemical control among high risk prostate cancer patients after external beam radiotherapy. Int J Radiat Oncol Biol Phys 56 (2003) 1234
9. Lyons J.A., Kupelian P.A., Mohan D.S., Reddy C.A., and Klein E.A. Importance of high radiation doses (72 Gy or greater) in the treatment of stage T1-T3 adenocarcinoma of the prostate. Urology 55 (2000) 85
10. Zelefsky M.J., Cowen D., Fuks Z., Shike M., Burman C., Jackson A., et al. Long term tolerance of high dose three dimensional conformal radiotherapy in patients with localized prostate cancer. Cancer 85 (1999) 2460
11. Storey M.R., Pollack A., Zagars G., Smith L., Antolak J., and Rosen I. Complications from radiotherapy dose escalation in prostate cancer. preliminary results of a randomized trial. Int J Radiat Oncol Biol Phys 48 (2000) 635
12. Jackson A., Skwarchuk M.W., Zelefsky M.J., Cowen D.M., Venkatraman E.S., Levegrun S., et al. Late rectal bleeding after conformal radiotherapy of prostate cancer. II. Volume effects and dose-volume histograms. Int J Radiat Oncol Biol Phys 49 (2001) 685
13. Zelefsky M.J., Fuks Z., Happersett L., Lee H.J., Ling C.C., Burman C.M., et al. Clinical experience with intensity modulated radiation therapy (IMRT) in prostate cancer. Radioth Oncol 55 (2000) 241
14. Burman C.M., Chui C.S., Kutcher G.J., Leibel S.A., Zelefsky M.J., LoSasso T.J., et al. Planning, delivery, and quality assurance of intensity-modulated radiotherapy using dynamic multileaf collimator. a strategy for large-scale implementation for the treatment of carcinoma of the prostate. Int J Radiat Oncol Biol Phys 39 (1997) 863
15. American Society for Therapeutic Radiology and Oncology Panel. Consensus statement. guidelines for PSA following radiation therapy. Int J Radiat Oncol Biol Phys 37 (1997) 1035
16. Thames E.M., Kuban D.A., Levy L.B., Horwitz E.M., Kupelian P.A., Martinez A.A., et al. Comparison of alternating biochemical failure definitions based on clinical outcome in 4839 prostate cancer patients treated by external radiation therapy between 1986 and 1995. Int J Radiat Oncol Biol Phys 57 (2003) 929
17. Kry S.F., Salehpour M., Followil D.S., Stoval M., Kuban D.A., White R.A., et al. The calculated risk of secondary fatal malignancies from intensity modulated radiation therapy. Int J Radiat Oncol Biol Phys 62 (2005) 1195
18. Della Biancia C., Hunt M., and Amols H. A comparison of the integral dose from 3D conformal and IMRT techniques in the treatment of prostate cancer. Med Phys 29 (2002) 1216